The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Brain : a journal of neurology

• Publication date

  1987-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/BRAIN/110.2.269PMID 3567525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two new mutants, ‘trembler’ and ‘reeler’, with neurological actions in the house mouse (Mus musculus L.)

  2008cited by this paper
• Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse

  2004cited by this paper
• X chromosome-linked muscular dystrophy (mdx) in the mouse.

  1984cited by this paper
• Muscle development in mdx mutant mice

  1984cited by this paper
• Paranodal dysmyelination and increase in tetrodotoxin binding sites in the sciatic nerve of the motor end-plate disease (med/med) mouse during postnatal development.

  1984cited by this paper
• Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity.

  1984cited by this paper
• Sampling schemes for estimating nerve fibre size. II. Methods for unifascicular nerve trunks.

  1984cited by this paper
• Postnatal growth and differentiation of muscle fibres in the mouse. I. A histochemical and morphometrical investigation of normal muscle.

  1983cited by this paper
• Changes produced by a hypomyelinating neuropathy in muscle and its innervation. Morphological and physiological studies in the Trembler mouse.

  1982cited by this paper
• Prevention of skeletal muscle fiber necrosis in hamster dystrophy

  1982cited by this paper
• Hereditary leucodystrophy in the mouse: the new mutant twitcher.

  1980cited by this paper
• Myopathology of myotonic dystrophy

  1979cited by this paper
• The ultrastructure of normal myogenesis in the limb of the mouse

  1978cited by this paper
• A new stain for quantitative measurement of sprouting at neuromuscular junctions

  1978cited by this paper
• MUSCULAR DYSGENESIS IN THE MOUSE (mdg/mdg) I. ULTRASTRUCTURAL STUDY OF SKELETAL AND CARDIAC MUSCLE

  1977cited by this paper
• The structure and composition of peripheral nerves and nerve roots in the Sprawling mouse.

  1977cited by this paper
• A comparison of the fine structure of motor end-plates in Duchenne dystrophy and in human neurogenic diseases.

  1976cited by this paper
• Myodystrophy, a new myopathy on chromosome 8 of the mouse.

  1976cited by this paper
• Neural abnormalities in the dystrophic mouse.

  1975cited by this paper
• Duchenne dystrophy

  1975cited by this paper
• Ultrastructure of motor end-plates during pharmacologically-induced degeneration and subsequent regeneration of skeletal muscle

  1975cited by this paper
• Fine structure of prenatal and early postnatal dystrophic mouse muscle.

  1975cited by this paper
• The neurological lesion in the dystrophic mouse.

  1974cited by this paper
• Changes in motor end-plates resulting from muscle fibre necrosis and regeneration. A light and electron microscopic study of the effects of the depolarizing fraction (cardiotoxin) of Dendroaspis jamesoni venom.

  1974cited by this paper
• Spinal cord limb motor neurones in muscular dystrophy.

  1974cited by this paper
• The regeneration of skeletal muscle. A review.

  1973cited by this paper
• Onion bulb neuropathy in the trembler mouse: A model of hypertrophic interstitial neuropathy (Dejerine-Sottas) in man

  1973cited by this paper
• Abnormalities of peripheral nerves in murine muscular dystrophy.

  1973cited by this paper
• Electrophysiological studies of neuromuscular transmission in hereditary ‘motor end‐plate disease’ of the mouse

  1971cited by this paper
• HISTOMETRIC ANALYSIS OF THE ULTRASTRUCTURE OF THE NEUROMUSCULAR JUNCTION IN MY ASTHENIA GRAVIS AND IN THE MYASTHENIC SYNDROME *

  1971cited by this paper
• THE ULTRASTRUCTURE OF THE NEUROMUSCULAR JUNCTIONS OF MAMMALIAN RED, WHITE, AND INTERMEDIATE SKELETAL MUSCLE FIBERS

  1970cited by this paper
• Muscle fiber types: how many and what kind?

  1970cited by this paper
• Hereditary motor end-plate disease in the mouse: light and electron microscopic studies.

  1970cited by this paper
• HYPOMYELINATION IN THE QUAKING MOUSE: A Model for the Analysis of Disturbed Myelin Formation

  1970cited by this paper
• Electron-microscopic structure of denervated skeletal muscle

  1969cited by this paper
• The central nervous system in Duchenne muscular dystrophy.

  1969cited by this paper
• An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'.

  1968cited by this paper
• Staining for nerve fiber and cholinesterase activity in fresh frozen sections.

  1967cited by this paper
• CHANGES IN MUSCLE STRUCTURE IN DYSTROPHIC PATIENTS, CARRIERS AND NORMAL SIBLINGS SEEN BY ELECTRON MICROSCOPY; CORRELATION WITH LEVELS OF SERUM CREATINEPHOSPHOKINASE (CPK) *

  1966cited by this paper
• DEVELOPMENTAL GENETICS OF A LETHAL MUTATION, MUSCULAR DYSGENESIS (MDG), IN THE MOUSE. II. DEVELOPMENTAL ANALYSIS.

  1965cited by this paper
• DEVELOPMENTAL GENETICS OF A LETHAL MUTATION, MUSCULAR DYSGENESIS (MDG), IN THE MOUSE. I. GENETIC ANALYSIS AND GROSS MORPHOLOGY.

  1965cited by this paper
• Mutant Mice (Quaking and Jimpy) with Deficient Myelination in the Central Nervous System

  1964cited by this paper
• CLINICAL AND PATHOLOGICAL STUDIES OF AN HEREDITARY NEUROPATHY IN MICE (DYSTONIA MUSCULORUM).

  1964cited by this paper
• A Simple Method for Preparing Serial Blocks of Tissue

  1956cited by this paper
• Dystrophia Muscularis: A HEREDITARY PRIMARY MYOPATHY IN THE HOUSE MOUSE.

  1955cited by this paper
• MODIFICATION OF THE GLEES SILVER IMPREGNATION FOR PARAFFIN SECTIONS

  1954cited by this paper
• A method for the combined staining of cells and fibers in the nervous system.

  1953cited by this paper

• Quantitative 3D assessment of muscle dystrophy through X-ray phase-contrast tomography

  2025cites this paper
• LEDT and Idebenone treatment modulate autophagy and improve regenerative capacity in the dystrophic muscle through an AMPK-pathway

  2024cites this paper
• Uncovering the Embryonic Origins of Duchenne Muscular Dystrophy.

  2024cites this paper
• Trilobatin contributes to the improvement of myopathy in a mouse model of Duchenne muscular dystrophy

  2024cites this paper
• Split intein-mediated protein trans-splicing to express large dystrophins

  2024cites this paper
• Respiratory Characterization of a Humanized Duchenne Muscular Dystrophy Mouse Model.

  2024cites this paper
• Accumulation of Dystrophin-Positive Muscle Fibers and Improvement of Neuromuscular Junctions in mdx Mouse Muscles after Bone Marrow Transplantation under Different Conditions

  2023cites this paper
• Antioxidant effects of LEDT in dystrophic muscle cells: involvement of PGC-1α and UCP-3 pathways

  2023cites this paper
• Does the Pathogenic Sequence of Skeletal Muscle Degeneration in Duchenne Muscular Dystrophy Begin and End with Unrestrained Satellite Cell Activation?

  2022cites this paper
• Cilostazol attenuates oxidative stress and apoptosis in the quadriceps muscle of the dystrophic mouse experimental model

  2022cites this paper
• Clinical aspects, food management, and clinical evolution of a cat with hypertrophic muscular dystrophy

  2022cites this paper
• Pregabalin synchronizes the regeneration of nerve and muscle fibers optimizing the gait recovery of MDX dystrophic mice

  2022cites this paper
• Macroglossia and less advanced dystrophic change in the tongue muscle of the Duchenne muscular dystrophy rat

  2022cites this paper
• Early Developmental Changes of Muscle Acetylcholine Receptors Are Little Influenced by Dystrophin Absence in mdx Mouse

  2022cites this paper
• Post-synaptic specialization of the neuromuscular junction: junctional folds formation, function, and disorders

  2022cites this paper
• Pharmacological inhibition of HDAC6 downregulates TGF-β via Smad2/3 acetylation and improves dystrophin-deficient muscles

  2022cites this paper
• Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation

  2022cites this paper
• Long lasting effect of acute restraint stress on behavior and brain anti-oxidative status

  2022cites this paper
• Antioxidant effects of bis-indole alkaloid indigo and related signaling pathways in the experimental model of Duchenne muscular dystrophy

  2022cites this paper
• Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases

  2021cites this paper
• Neuromuscular Development and Disease: Learning From in vitro and in vivo Models

  2021cites this paper
• Histological Analysis of Tibialis Anterior Muscle of DMDmdx4Cv Mice from 1 to 24 Months

  2021cites this paper
• Beneficial Role of Exercise in the Modulation of mdx Muscle Plastic Remodeling and Oxidative Stress

  2021cites this paper
• Metformin Increases Sarcolemma Integrity and Ameliorates Neuromuscular Deficits in a Murine Model of Duchenne Muscular Dystrophy

  2021cites this paper
• Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

  2021cites this paper
• The role of the Dystrophin Glycoprotein Complex on the Neuromuscular System.

  2020cites this paper
• Implications of increased S100β and Tau5 proteins in dystrophic nerves of two mdx mouse models for Duchenne muscular dystrophy.

  2020cites this paper
• Modulating gene regulation to treat genetic disorders

  2020cites this paper
• Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: Impacts, challenges, and opportunities

  2020cites this paper
• Cardiac lesions in Duchenne muscular dystrophy model rats with out-of-frame Dmd gene mutation mediated by CRISPR/Cas9 system

  2020cites this paper
• Dystrophic Dmdmdx rats show early neuronal changes (increased S100β and Tau5) at 8 months, supporting severe dystropathology in this rodent model of Duchenne Muscular Dystrophy.

  2020cites this paper
• Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin‐deficient mdx mice

  2020cites this paper
• Modulating gene regulation to treat genetic disorders

  2020cites this paper
• The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis

  2020cites this paper
• Tempol treatment shows phenotype improvement in mdx mice

  2019cites this paper
• Effects of chronic treatment with gold nanoparticles on inflammatory responses and oxidative stress in Mdx mice

  2019cites this paper
• QuantiMus: A Machine Learning-Based Approach for High Precision Analysis of Skeletal Muscle Morphology

  2019influential citation
• Identification of quantitative trait loci affecting wet carcass syndrome in sheep using high density snp genotypes

  2018cites this paper
• Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4

  2018cites this paper
• Dystrophin As a Molecular Shock Absorber.

  2018cites this paper
• Sex influences diaphragm muscle response in exercised mdx mice

  2018cites this paper
• Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression

  2018cites this paper
• Invaginating Presynaptic Terminals in Neuromuscular Junctions, Photoreceptor Terminals, and Other Synapses of Animals

  2017cites this paper
• Congenital muscle dystrophy and diet consistency affect mouse skull shape differently

  2017cites this paper
• P2RX7 purinoceptor as a therapeutic target in Duchenne muscular dystrophy

  2017cites this paper
• Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction

  2017cites this paper
• Does Sarcolipin Ablation Alter Deflazacort Treatment Effects in mdx Mice

  2017cites this paper
• Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.

  2016cites this paper
• The weak combined magnetic field, tuned to ion parametric resonance for Ca2+, stimulates dystrophin synthesis in the skeletal muscles of mdx mice subjected to cell therapy

  2016cites this paper
• Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle

  2016cites this paper
• Incessant cycles of dystrophic myofiber degeneration and regeneration result in ubiquitous centrally-nucleated fibers in skeletal muscles of X-chromosome-linked muscular dystrophy (mdx) mouse

  2016cites this paper
• ROLE OF SH3 AND CYSTEINE-RICH DOMAIN 3 (STAC3) IN SKELETAL MUSCLE DEVELOPMENT, POSTNATAL GROWTH AND CONTRACTION

  2016cites this paper
• Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

  2016cites this paper
• Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

  2016cites this paper
• Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models

  2016cites this paper
• Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle

  2016cites this paper
• Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice

  2015influential citation
• mice prevents the occurrence of muscle degeneration mdx Hindlimb immobilization applied to 21-day-old

  2015cites this paper
• Drug Discovery of Therapies for Duchenne Muscular Dystrophy

  2015cites this paper
• Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine

  2015cites this paper
• The burrowing behavior of the nematode Caenorhabditis elegans: a new assay for the study of neuromuscular disorders

  2015cites this paper
• muscular dystrophy The role of free radicals in the pathophysiology of

  2015cites this paper
• Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.

  2015cites this paper
• Combinatorial Utrophin A Activation in Muscle as a Therapeutic Strategy to Treat Duchenne Muscular Dystrophy

  2015cites this paper
• A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice

  2014cites this paper
• Measurement of Passive Skeletal Muscle Mechanical Properties In Vivo: Recent Progress, Clinical Applications, and Remaining Challenges

  2014cites this paper
• Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy

  2014cites this paper
• Regulation of Nicotinic Acetylcholine Receptor Stability at the Mouse Neuromuscular Junction.

  2014cites this paper
• Histological assessment of mdx mice treated with antioxidant supplementation

  2014cites this paper
• What do mouse models of muscular dystrophy tell us about the DAPC and its components?

  2014cites this paper
• Fibromodulin and Dystrophin in Atherosclerosis: Novel roles for extracellular matrix in plaque development

  2014cites this paper
• Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability.

  2014cites this paper
• SMASH – semi-automatic muscle analysis using segmentation of histology: a MATLAB application

  2014cites this paper
• In vivo anisotropic mechanical properties of dystrophic skeletal muscles measured by anisotropic MR elastographic imaging: the mdx mouse model of muscular dystrophy.

  2014cites this paper
• Three-dimensional optical coherence micro-elastography of skeletal muscle tissue.

  2014cites this paper
• The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice

  2014cites this paper
• Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin‐deficient muscle

  2014cites this paper
• Prosaposin expression in the regenerated muscles of mdx and cardiotoxin-treated mice.

  2013cites this paper
• Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice

  2013cites this paper
• Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy.

  2013cites this paper
• N-Butyryl arginine and 3-Hydroxybutyrate arginine, for the treatment of DMD through oral administration

  2013cites this paper
• Dystrophin and utrophin “double knockout” dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities

  2013cites this paper
• Cyclooxygenase-2 expression in skeletal muscle of knockout mice suffering Duchenne muscular dystrophy

  2013cites this paper
• Dynamics of nicotinic acetylcholine receptors and receptor-associated proteins at the vertebrate neuromuscular junction.

  2013cites this paper
• Combining MR elastography and diffusion tensor imaging for the assessment of anisotropic mechanical properties: A phantom study

  2013cites this paper
• Cardiac and Respiratory Dysfunction in Duchenne Muscular Dystrophy and the Role of Second Messengers

  2013cites this paper
• Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy

  2013cites this paper
• Role of Telomere Dysfunction in Cardiac Failure in Duchenne Muscular Dystrophy

  2013cites this paper
• Alterations of cAMP-dependent signaling in dystrophic skeletal muscle

  2013influential citation
• AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.

  2013cites this paper
• Participation of Myosin Va and Pka Type I in the Regeneration of Neuromuscular Junctions

  2012cites this paper
• β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.

  2012cites this paper
• Granulocyte-Colony Stimulating Factor Improves MDX Mouse Response to Peripheral Nerve Injury

  2012cites this paper
• Muscle function and running activity in mouse models of hereditary muscle dystrophy: Impact of double knockout for dystrophin and the transcription factor MyoD

  2012cites this paper
• Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods.

  2012cites this paper
• Motor performance of young dystrophic mdx mice treated with long‐circulating prednisolone liposomes

  2012cites this paper
• Distinct Effects of Contraction-Induced Injury In Vivo on Four Different Murine Models of Dysferlinopathy

  2012cites this paper
• The paradox of muscle hypertrophy in muscular dystrophy.

  2012cites this paper
• Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice.

  2012cites this paper
• Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy

  2012cites this paper